GENOME SEQUENCING OF A CAMELPOX VACCINE REVEALS CLOSE SIMILARITY TO MODIFIED VACCINIA VIRUS ANKARA (MVA)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Blog Article

Camelpox is a viral contagious disease of Old-World camelids sustained by Camelpox virus (CMLV).The disease is characterized by mild, local skin Lithium or severe systemic infections and may have a major economic impact due to significant losses in terms of morbidity and mortality, weight VITAMIN C CRYSTALS loss, and low milk yield.Prevention of camelpox is performed by vaccination.

In this study, we investigated the composition of a CMLV-based, live-attenuated commercial vaccine using next-generation sequencing (NGS) technology.The results of this analysis revealed genomic sequences of Modified Vaccinia virus Ankara (MVA).

Report this page